U.S. Markets close in 44 mins.

Champions Oncology, Inc. (CSBR)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.7472+0.0572 (+2.1264%)
As of 2:48PM EDT. Market open.
People also watch
CGNTEYEGZSANCRTNCLRB
Full screen
Previous Close2.6900
Open2.6600
Bid2.7100 x 100
Ask2.7500 x 3100
Day's Range2.6427 - 2.8700
52 Week Range1.1100 - 4.7900
Volume40,880
Avg. Volume15,709
Market Cap30.16M
Beta-0.59
PE Ratio (TTM)-3.82
EPS (TTM)-0.72
Earnings DateJul 27, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire8 days ago

    Champions Oncology Schedules Fourth Quarter and Fiscal Year 2017 Earnings Call

    HACKENSACK, N.J., July 17, 2017 /PRNewswire/ -- Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the fourth quarter and fiscal year ended April 30, 2017, on Thursday, July 27, 2017, after market close. The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST). A replay of the call will be available on the Investor tab of the company's website within 72 hours.

  • Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017
    Capital Cube4 months ago

    Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017

    Categories: Yahoo Finance Get free summary analysis Champions Oncology, Inc. reports financial results for the quarter ended January 31, 2017. We analyze the earnings along side the following peers of Champions Oncology, Inc. – Aviragen Therapeutics Inc, Charles River Laboratories International, Inc., Exelixis, Inc., Heska Corporation, NanoString Technologies, Inc., Celldex Therapeutics, Inc. and Foundation Medicine, Inc. (AVIR-US, CRL-US, ... Read more (Read more...)

  • PR Newswire4 months ago

    Champions Oncology Reports 40% Revenue Growth

    HACKENSACK, N.J., March 16, 2017 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use ...